Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study.

R FernandesS MazzarelloA A JoyG R PondJ HiltonM F K IbrahimC CanilM OngC StoberL VandermeerB HuttonM da CostaS DamarajuMark Clemons

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2018)

TAPS is common after taxane-based chemotherapy, and its presence is associated with reduced quality of life and increased analgesic requirements. Prospective patient-reported outcome assessments are crucial to help individualize treatment strategies and improve management of TAPS.

Keyphrases

patient reported outcomes
prostate cancer
locally advanced
liver failure
radical prostatectomy
metastatic breast cancer
respiratory failure
drug induced
neuropathic pain
anti inflammatory
radiation therapy
spinal cord injury
chemotherapy induced
rectal cancer
hepatitis b virus
extracorporeal membrane oxygenation